文献速递生殖医学

卵泡期长方案全程添加hMG可改善非高龄卵巢储备正常患者妊娠结局

[Clinical effect of adding hMG to the follicular phase long protocol for standard group with normal ovarian reserve function].
PubMed 文献 · Zhonghua Fu Chan Ke Za Zhi · 2021-01-01

该回顾性研究分析了489例非高龄、卵巢储备功能正常且首次行体外受精采用卵泡期长方案的新鲜周期患者,按是否添加hMG及添加时机分为不添加组、中期添加组和全程添加组。结果显示全程添加hMG组优质胚胎率、临床妊娠率(76.7%)和活产率(67.3%)显著高于其他两组,结论认为全程添加hMG可通过提高胚胎质量改善妊娠结局。

要点

  • 非高龄卵巢储备正常者采用卵泡期长方案时,全程添加hMG可提高优质胚胎率。
  • 全程添加hMG组临床妊娠率76.7%、活产率67.3%,显著高于不添加和中期添加组。
  • 中期添加hMG组胚胎种植率显著低于不添加组和全程添加组。

核心结论

  • 对于非高龄且卵巢储备功能正常的标准人群中卵巢储备功能相对较低者,采用卵泡期长方案时在GnRH激动剂降调节后促排卵过程中全程添加hMG,可通过提高胚胎质量改善妊娠结局。

研究设计与样本

  • 回顾性分析2018年1月至2020年1月贵州医科大学附属医院489例卵巢储备功能正常、非高龄、首次行体外受精采用卵泡期长方案新鲜周期的患者临床资料。
  • 按是否添加hMG及添加时机分为不添加hMG组(76例)、中期添加hMG组(211例)、全程添加hMG组(202例)。

主要发现

  • 中期添加组和全程添加组年龄均显著高于不添加组(P=0.019、P=0.011)。
  • 全程添加组基础FSH显著高于不添加组(P<0.01)和中期添加组(P=0.006),基础FSH/LH比值显著高于中期添加组(P=0.009)。
  • 不添加组和中期添加组窦卵泡数显著高于全程添加组(P=0.007、P=0.017)。
  • 全程添加组优质胚胎率[(47±27)%]显著高于不添加组(P=0.017);中期添加组胚胎种植率显著低于不添加组和全程添加组(P=0.043、P<0.01)。
  • 全程添加组临床妊娠率[76.7%(155/202)]显著高于不添加组(P=0.039)和中期添加组(P<0.01);活产率[67.3%(136/202)]显著高于不添加组(P=0.017)和中期添加组(P=0.001)。

临床怎么用

  • 对非高龄、卵巢储备功能正常但储备相对较低的患者,卵泡期长方案促排卵时可考虑全程添加hMG以改善妊娠结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To investigate the impact of adding human menopausal gonadotropin (hMG) for in vitro fertilization-embryo transfer pregnancy outcomes in a standard population of non-advanced age with normal ovarian reserve function using a long follicular phase protocol. Methods: Clinical data of 489 patients with normal ovarian reserve function, who were admitted from January 2018 to January 2020 in the Affiliated Hospital of Guizhou Medical University and underwent in vitro fertilization for the first time with the long follicular phase protocol in fresh cycles, were retrospectively analyzed. The patients were divided into three groups according to whether or not to add urine-derived hMG and the timing of addition: non-addition group (group A), medium-term hMG group (group B1), whole course hMG group (group B2); the laboratory parameters of each group were observed, and the effect of ovulation induction drugs and pregnancy outcomes were compared. Results: The ages of B1 and B2 groups were significantly higher than that of group A (P=0.019 and P=0.011). The basal FSH level of group B2 was significantly higher than those of group A and group B1 (P<0.01 and P=0.006), and the basal FSH/LH ratio of group B2 was significantly higher than that of group B1 (P=0.009). Antral follicle counts of group A and group B1 were significantly higher than that of group B2 (P=0.007 and P=0.017). The superior embryo rate of group B2 [(47±27)%] was significantly higher than that of group A (P=0.017). The embryo implantation rate of group B1 was significantly lower than those of group A and group B2 (P=0.043 and P<0.01). The clinical pregnancy rate of group B2 [76.7% (155/202)] was significantly higher than those of group A (P=0.039) and group B1 (P<0.01). The live-birth rate of group B2 [67.3% (136/202)] was significantly higher than those of group A (P=0.017) and group B1 (P=0.001). Conclusions: For non-advanced aged patients with normal ovarian reserve function, the long protocol of follicular phase is suitable for those with relatively low ovarian reserve function. Adding hMG in the whole course of ovulation induction after gonadotropin-releasing hormone agonist reduction could improve the pregnancy outcomes by improving the quality of embryos. 目的: 探讨在卵泡期长方案中添加人绝经期促性腺激素(hMG)对于体外受精-胚胎移植且卵巢储备功能正常的非高龄患者妊娠结局的影响。 方法: 收集2018年1月至2020年1月在贵州医科大学附属医院生殖中心就诊的卵巢储备功能正常、非高龄患者489例,且为首次行体外受精、采用卵泡期长方案促排卵的新鲜周期,回顾性分析其临床资料。根据患者是否添加hMG及添加时机分为3组:不添加hMG组(76例)、中期添加hMG组(211例)、全程添加hMG组(202例),比较各组的基本情况、促排卵药物的效果及妊娠结局。 结果: 中期添加hMG组和全程添加hMG组的年龄均明显高于不添加hMG组(P值分别为0.019、0.011);全程添加hMG组的基础FSH水平明显高于不添加hMG组(P<0.01)和中期添加hMG组(P=0.006),基础FSH/LH比值明显高于中期添加hMG组(P=0.009);不添加hMG组和中期添加hMG组的窦卵泡数明显高于全程添加hMG组(P值分别为0.007、0.017)。全程添加hMG组的优质胚胎率[(47±27)%]明显高于不添加hMG组(P=0.017);中期添加hMG组的胚胎种植率明显低于不添加hMG组和全程添加hMG组(P值分别为0.043及<0.01)。全程添加hMG组的临床妊娠率[76.7%(155/202)]高于不添加hMG组(P=0.039)和中期添加hMG组(P<0.01);全程添加hMG组的活产率[67.3%(136/202)]明显高于不添加hMG组(P=0.017)和中期添加hMG组(P=0.001)。 结论: 就非高龄且卵巢储备功能正常的标准人群中卵巢储备功能相对较低者采用卵泡期长方案,在促性腺激素释放激素激动剂降调节后的促排卵过程中全程添加hMG,可通过提高胚胎的质量而改善妊娠结局。.

来源:Zhonghua Fu Chan Ke Za Zhi,查看原文。版权归原作者所有。

引用

  1. Liang YY, Zhao SY, Huang GY, et al. [Clinical effect of adding hMG to the follicular phase long protocol for standard group with normal ovarian reserve function]. Zhonghua Fu Chan Ke Za Zhi. 2021. PMID: 34034420. doi:10.3760/cma.j.cn112141-20210327-00155

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。